Annual report for BSL Ltd. for FY-2021
08-06-2021
BSL Ltd - 514045 - Announcement under Regulation 30 (LODR)-Change in Directorate
In accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Board of Directors of the Company has passed the resolution by circulation on 7th June, 2021 for cooption of Shri Praveen Kumar Jain (DIN: 0009196198) on the Board of Directors of the Company as an Additional Director (Operations) with immediate effect, subject to the approval of the Members in the General Meeting. As per SEBI Circular CIR/CFD/CMD/4/2015 dated 9th September 2015 a brief profile of Shri Praveen Kumar Jain is attached as per Annexure-A. Please also note that Shri Praveen Kumar Jain is not debarred from holding the office of Director pursuant to any SEBI order or any other such authority. You are requested to take above information on record.07-06-2021
BSL Ltd - 514045 - Outcome Of Board Meeting Held On 7Th June, 2021
Outcome of Board Meeting held on 7th June, 202107-06-2021
BSL LTD. - 514045 - Results-Financial Results For March 31, 2021.
Outcome of Board Meeting held on 7th June, 2021 through Circulation, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201507-06-2021
BSL Ltd - 514045 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Notice of Board Meeting to be held on 7th June, 202129-05-2021
BSL Ltd - 514045 - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For Quarter And Year Ended 31St March, 2021 And Recommendation Of Dividend, If Any, For The Financial Year 2020-21.
BSL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/06/2021 ,inter alia, to consider and approve 1. Audited Financial Results for quarter and year ended 31st March, 2021. 2. To consider the recommendation of Dividend, if any, for the financial year 2020-21.27-05-2021
Bharat Biotech agrees to open Covaxin manufacturing to others
Bharat Biotech has been producing Covaxin at its Biosafety Level-3 (BSL-3) facilities in Hyderabad and Bengaluru, where Production capacity had been enhanced in a step-wise manner13-05-2021
BSL LTD. - 514045 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation Regarding Loss of Share Certificate04-05-2021
BSL Ltd - 514045 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayBSL LTD. 2CINL24302RJ1970PLC002266 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 43.32 4Highest Credit Rating during the previous FY BBB+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)BRICKWORK RATINGS INDIA PRIVATE LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: AANCHAL PATNI Designation: COMPANY SECRETARY EmailId: [email protected] Name of the Chief Financial Officer: PRAVEEN JAIN Designation: PRESIDENT AND CHIEF FINANCIAL OFFICER EmailId: [email protected] Date: 14/04/2021 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.14-04-2021
BSL Ltd - 514045 - Shareholding for the Period Ended March 31, 2021
BSL Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here14-04-2021